Overview of Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitors for the Treatment of Non-diabetic Heart Failure Patients

Heart failure (HF) is a clinical syndrome that results from any structural or functional impairment of ventricular filling or ejection of blood, and results in low life quality and expectancy, creating a significant burden on the healthcare system. The pharmacological HF management has remained unch...

Descripción completa

Detalles Bibliográficos
Autores principales: Balan, Irina, Khayo, Tetyana, Sultanova, Sevara, Lomakina, Yuliia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434761/
https://www.ncbi.nlm.nih.gov/pubmed/34527497
http://dx.doi.org/10.7759/cureus.17118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434761/
https://www.ncbi.nlm.nih.gov/pubmed/34527497
http://dx.doi.org/10.7759/cureus.17118

Ejemplares similares